These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6390637)

  • 1. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.
    Brook I
    Rev Infect Dis; 1984; 6(5):601-7. PubMed ID: 6390637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.
    Brook I
    J Fam Pract; 1994 Feb; 38(2):175-9. PubMed ID: 8308510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis.
    Brook I; Gober AE
    Arch Otolaryngol Head Neck Surg; 1995 Dec; 121(12):1405-9. PubMed ID: 7488371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management.
    Brook I
    J Otolaryngol; 2001 Dec; 30(6):324-9. PubMed ID: 11771001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The presence of beta-lactamase-producing bacteria as a guideline in the management of children with recurrent tonsillitis.
    Brook I
    Am J Otolaryngol; 1984; 5(6):382-6. PubMed ID: 6400716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin.
    Brook I; Hirokawa R
    Clin Pediatr (Phila); 1985 Jun; 24(6):331-6. PubMed ID: 3888491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to eradicate streptococci and beta-lactamase producing bacteria.
    Brook I; Gober AE
    Acta Paediatr; 2008 Feb; 97(2):193-5. PubMed ID: 18254908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of methicillin resistant Staphylococcus aureus from the surface and core of tonsils in children.
    Brook I; Foote PA
    Int J Pediatr Otorhinolaryngol; 2006 Dec; 70(12):2099-102. PubMed ID: 16962178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.
    Brook I
    Int J Pediatr Otorhinolaryngol; 2007 Oct; 71(10):1501-8. PubMed ID: 17644191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the microbiology of group A and non-group A streptococcal tonsillitis.
    Brook I; Yocum P
    Ann Otol Rhinol Laryngol; 1988; 97(3 Pt 1):243-6. PubMed ID: 3132074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium.
    Brook I
    J Antimicrob Chemother; 1989 Aug; 24(2):227-33. PubMed ID: 2676941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci.
    Brook I
    Pediatr Infect Dis; 1985; 4(5):491-5. PubMed ID: 3931058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of beta lactamase in tonsils of children with recurrent tonsillitis.
    Brook I; Yocum P
    Acta Otolaryngol; 1984; 98(5-6):556-9. PubMed ID: 6395621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis.
    Brook I
    Int J Antimicrob Agents; 2001 Jun; 17(6):439-42. PubMed ID: 11397612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonsillar microbial flora: comparison of recurrent tonsillitis and normal tonsils.
    Stjernquist-Desatnik A; Holst E
    Acta Otolaryngol; 1999 Jan; 119(1):102-6. PubMed ID: 10219395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers.
    Brook I; Gober AE
    J Med Microbiol; 2006 Dec; 55(Pt 12):1741-1744. PubMed ID: 17108280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.
    Brook I; Gilmore JD
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1452-5. PubMed ID: 8363375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis.
    Tanz RR; Shulman ST; Sroka PA; Marubio S; Brook I; Yogev R
    J Pediatr; 1990 Dec; 117(6):859-63. PubMed ID: 2123240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased recovery of Moraxella catarrhalis and Haemophilus influenzae in association with group A beta-haemolytic streptococci in healthy children and those with pharyngo-tonsillitis.
    Brook I; Gober AE
    J Med Microbiol; 2006 Aug; 55(Pt 8):989-992. PubMed ID: 16849717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.